The project used thousands of agents to search data drawn from millions of brain cells and generate research leads.
The source presents the system as a way to scale exploration of large biological datasets. It describes parallel agent work rather than a single model response, with the stated output being candidate directions for researchers to investigate.
The publication does not establish that any lead has been experimentally validated, that it has clinical relevance, or that the agents discovered a confirmed causal mechanism. It also does not provide a public product release, access terms, pricing, or an independent reproducibility evaluation.
OpenAI's account is a case study by one of the participating organizations. The source supports that the collaboration ran this agent-based analysis; it does not by itself support broader claims about scientific reliability or laboratory outcomes.